期刊文献+

高效液相色谱法测定大鼠血清中盐酸柔红霉素浓度 被引量:1

Determination of Concentration of Daunorubicin Hydrochloride in Rat Serum by HPLC
下载PDF
导出
摘要 目的建立测定大鼠血清中柔红霉素血药浓度的高效液相色谱法。方法色谱柱为Phenomenex C18柱(250 mm×4.6 mm,5μm),流动相为甲醇-0.01 mol/L磷酸二氢铵溶液(pH=4.65)-冰醋酸(30∶20∶0.1),流速1.0 mL/min,检测波长233 nm,柱温35℃,内标为盐酸多柔比星,进样量20μL。结果盐酸柔红霉素质量浓度在0.147 8~14.77 8 mg/L(r=0.998 4)范围内与待测物和内标峰高比值线性关系良好,低、中、高3种质量浓度(0.738 9,3.694 5,14.778 0 mg/L)的平均相对回收率分别为102.5%,98.7%,99.3%,日内、日间RSD均小于10%。结论该方法样品处理简便,可用于血清中盐酸柔红霉素的血药浓度测定和药代动力学研究。 Objective To establish the determination method of serum concentration of daunorubicin hydrochloride by HPLC.Methods The samples were separated on the Phenomenex C18 column(250 mm×4.6 mm,5 μm) with the mobile phase consisted of methanol-0.01 mol/L ammonium dihydrogen phosphate solution(pH=4.65)-glacial acetic acid(30 ∶20 ∶0.1) at the flow rate of 1.0 mL/min.The UV detection wavelength was 233 nm.The column temperature was 35℃.The internal standard was doxorubicin hydrochloride.The injection volume was 20 μL.Results The linear range for daunorubicin hydrochloride was 0.147 8-14.77 8 mg/L(r=0.998 4).The mean relative recovery rates of daunorubicin hydrochloride at low,middle and high concentrations(0.738 9,3.694 5,14.778 0 mg/L)were 102.5%,98.7%and 99.3%,respectively.Both intra-day and inter-day RSD were below 10%.Conclusion This method is simple and suitable for blood concentration monitoring and pharmacokinetic study of daunorubicin hydrochloride.
出处 《中国药业》 CAS 2012年第2期27-28,共2页 China Pharmaceuticals
关键词 盐酸柔红霉素 血药浓度 高效液相色谱法 daunorubicin hydrochloride serum concentration HPLC
  • 相关文献

参考文献2

二级参考文献7

  • 1Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids [J]. J Mol Biol, 1965,13(2):238-252. 被引量:1
  • 2Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery [J]. Trends Pharmacol Sci, 1994,15(7):215-220. 被引量:1
  • 3Nagayasu A, Shimooka Y, Kinouchi T, et al. Effects of fluidity and vesicle size on antitumor activity and myelosuppressive activity of liposomes loaded with daunorubicin [J]. Biol Pharm Bull, 1994,17(7):935-939. 被引量:1
  • 4Nagayasu A, Uchiyama K, Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs [J]. Adv Drug Deliv Rev, 1999,40(1):75-87. 被引量:1
  • 5Forssen EA, Ross ME. Daunoxome treatment of solid tumers:preclinical and clinical investigations [J]. J Liposome Res, 1994,4(1):481-512. 被引量:1
  • 6The Pharmacopoeia commission of PRC. Pharmacopoeia of the Peoples′s Republic of China [M]. Section II. Beijing: Chemical Industry Press, 2000.Appendix 202. 被引量:1
  • 7Espino BM, Muggia F, Cabriales S, et al. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin [J]. J Clin Oncol, 1995,13(4):996-1003. 被引量:1

共引文献12

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部